What is the purpose of interpretive breakpoints in antimicrobial susceptibility testing?

• A. To convert zone diameters into antibiotic doses in patients.
• B. To standardize laboratory protocols across laboratories irrespective of data.
• C. To classify organisms as susceptible, intermediate, or resistant using MIC or zone data.
• D. To determine the pharmacokinetics of antibiotics in the body.

Answer: (C)

Interpretive breakpoints are the thresholds that translate lab measurements into clinical categories. They take the MIC value or the zone diameter from disk diffusion and classify the organism as susceptible, intermediate, or resistant. This classification isn’t about exact dosing or pharmacokinetics itself; it’s about predicting whether a standard antibiotic regimen is likely to work in a patient. Breakpoints are set using pharmacokinetic and pharmacodynamic considerations, the drug concentrations that can be achieved at the infection site, clinical outcomes, and known resistance mechanisms, so clinicians can choose an effective antibiotic and dosing strategy. The idea is to standardize how results are interpreted across settings and to guide therapy, rather than to convert measurements into doses or to determine the drug’s PK profile.